[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Medical News & Perspectives
August NaN, 2001

New Advice for Women Patients About Hormone Therapy and the Heart

Author Affiliations

Not Available

Not Available

JAMA. 2001;286(8):907. doi:10.1001/jama.286.8.907-JMN0822-2-1

After years of taking the opposite tack, the American Heart Association (AHA) is recommending that hormone replacement therapy (HRT) should not be initiated for secondary prevention of cardiovascular disease (CVD) in postmenopausal women.

The recommendation follows results from clinical trials suggesting that no overall cardiovascular benefit results, and a possible early increased risk of CVD events occurs, when women with documented atherosclerosis begin to take HRT (estrogen typically combined with a progestin).

First Page Preview View Large
First page PDF preview
First page PDF preview